BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chen H, Shen ZY, Xu W, Fan TY, Li J, Lu YF, Cheng ML, Liu J. Expression of P450 and nuclear receptors in normal and end-stage Chinese livers. World J Gastroenterol 2014; 20(26): 8681-8690 [PMID: 25024626 DOI: 10.3748/wjg.v20.i26.8681]
URL: https://www.wjgnet.com/1007-9327/full/v20/i26/8681.htm
Number Citing Articles
1
Ai-Guo Wang, Ya-Nan Song, Jun Chen, Hui-Ling Li, Jian-Yi Dong, Hai-Peng Cui, Liang Yao, Xue-Feng Li, Wen-Ting Gao, Ze-Wen Qiu, Fu-Jin Wang, Jing-Yu Wang. Activation of RAS/ERK alone is insufficient to inhibit RXRα function and deplete retinoic acid in hepatocytesBiochemical and Biophysical Research Communications 2014; 452(3): 801 doi: 10.1016/j.bbrc.2014.09.007
2
Lili Niu, Philipp E Geyer, Rajat Gupta, Alberto Santos, Florian Meier, Sophia Doll, Nicolai J Wewer Albrechtsen, Sabine Klein, Cristina Ortiz, Frank E Uschner, Robert Schierwagen, Jonel Trebicka, Matthias Mann. Dynamic human liver proteome atlas reveals functional insights into disease pathwaysMolecular Systems Biology 2022; 18(5) doi: 10.15252/msb.202210947
3
Elsa Lilienberg, Ilse R. Dubbelboer, Amar Karalli, Rimma Axelsson, Torkel B. Brismar, Charlotte Ebeling Barbier, Agneta Norén, Frans Duraj, Mikael Hedeland, Ulf Bondesson, Erik Sjögren, Per Stål, Rickard Nyman, Hans Lennernäs. In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular CarcinomaMolecular Pharmaceutics 2017; 14(2): 448 doi: 10.1021/acs.molpharmaceut.6b00886
4
Human Drug Metabolism2020; : 331 doi: 10.1002/9781119658016.ch7
5
Meng-Hui Zhang, Qin-Hai Shen, Zhao-Min Qin, Qiao-Ling Wang, Xi Chen. Systematic tracking of disrupted modules identifies significant genes and pathways in hepatocellular carcinomaOncology Letters 2016; 12(5): 3285 doi: 10.3892/ol.2016.5039
6
Dong Gui Hu, Shashikanth Marri, Ross A. McKinnon, Peter I. Mackenzie, Robyn Meech. Deregulation of the Genes that Are Involved in Drug Absorption, Distribution, Metabolism, and Excretion in Hepatocellular CarcinomaJournal of Pharmacology and Experimental Therapeutics 2019; 368(3): 363 doi: 10.1124/jpet.118.255018
7
Naoko Takebe, Jan H. Beumer, Shivaani Kummar, Brian F. Kiesel, Afshin Dowlati, Geraldine O'Sullivan Coyne, Richard Piekarz, Lawrence Rubinstein, Laura K. Fogli, Ulka Vaishampayan, Sanjay Goel, Cindy L. O'Bryant, Bassel F. El‐Rayes, Vincent Chung, Heinz‐Josef Lenz, Richard Kim, Chandra P. Belani, Joseph M. Tuscano, William Schelman, Nancy Moore, James H. Doroshow, Alice P. Chen. A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunctionBritish Journal of Clinical Pharmacology 2019; 85(11): 2499 doi: 10.1111/bcp.14054
8
Sylwia Szeląg-Pieniek, Stefan Oswald, Mariola Post, Joanna Łapczuk-Romańska, Marek Droździk, Mateusz Kurzawski. Hepatic drug-metabolizing enzymes and drug transporters in Wilson’s disease patients with liver failurePharmacological Reports 2021; 73(5): 1427 doi: 10.1007/s43440-021-00290-8
9
Patrick C. Flannery, Kodye L. Abbott, Satyanarayana R. Pondugula. Correlation of PPM1A Downregulation with CYP3A4 Repression in the Tumor Liver Tissue of Hepatocellular Carcinoma PatientsEuropean Journal of Drug Metabolism and Pharmacokinetics 2020; 45(2): 297 doi: 10.1007/s13318-019-00595-3
10
Xianmei Lv, Gaochen Lan, Lujian Zhu, Qiusheng Guo. Breaking the Barriers of Therapy Resistance: Harnessing Ferroptosis for Effective Hepatocellular Carcinoma TherapyJournal of Hepatocellular Carcinoma 2024; : 1265 doi: 10.2147/JHC.S469449
11
Xiaoning Gan, Yue Luo, Guanqi Dai, Junhao Lin, Xinhui Liu, Xiangqun Zhang, Aimin Li. Identification of Gene Signatures for Diagnosis and Prognosis of Hepatocellular Carcinomas Patients at Early StageFrontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00857
12
Kangning Zhu, Jing Li, Boya Chen, Xin Liu. A Bayesian-based Approach for Identification of Potential Protein Biomarkers in Hepatocellular CarcinomaProceedings of the 2023 15th International Conference on Bioinformatics and Biomedical Technology 2023; : 110 doi: 10.1145/3608164.3608214
13
Huan Li, Yuan-Fu Lu, Hong Chen, Jie Liu. Dysregulation of metallothionein and circadian genes in human hepatocellular carcinomaChronobiology International 2017; 34(2): 192 doi: 10.1080/07420528.2016.1256300
14
Jose J. G. Marin, Candela Cives-Losada, Maitane Asensio, Elisa Lozano, Oscar Briz, Rocio I. R. Macias. Mechanisms of Anticancer Drug Resistance in HepatoblastomaCancers 2019; 11(3): 407 doi: 10.3390/cancers11030407
15
Nan Hu, Yanjuan Huang, Xuejiao Gao, Sai Li, Zhixiang Yan, Bin Wei, Ru Yan. Effects of dextran sulfate sodium induced experimental colitis on cytochrome P450 activities in rat liver, kidney and intestineChemico-Biological Interactions 2017; 271: 48 doi: 10.1016/j.cbi.2017.04.018
16
Yoichi Sasaki, Ryotaro Sakamori, Ryoko Yamada, Minoru Shigekawa, Yuki Tahata, Yuki Makino, Tasuku Nakabori, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara. Cotreatment with lenvatinib and warfarin potassium caused prothrombin time prolongationHepatology Research 2019; 49(11): 1357 doi: 10.1111/hepr.13379
17
Wufeng Fan, Guangming Ye. Microarray analysis for the identification of specific proteins and functional modules involved in the process of hepatocellular carcinoma originating from cirrhotic liverMolecular Medicine Reports 2018;  doi: 10.3892/mmr.2018.8555
18
Joseph M. Collins, Danxin Wang. Cytochrome P450 3A4 (CYP3A4) protein quantification using capillary western blot technology and total protein normalizationJournal of Pharmacological and Toxicological Methods 2021; 112: 107117 doi: 10.1016/j.vascn.2021.107117
19
Basma Hossam Abdelmonem, Noha M. Abdelaal, Eman K. E. Anwer, Alaa A. Rashwan, Mohamed Ali Hussein, Yasmin F. Ahmed, Rana Khashana, Mireille M. Hanna, Anwar Abdelnaser. Decoding the Role of CYP450 Enzymes in Metabolism and Disease: A Comprehensive ReviewBiomedicines 2024; 12(7): 1467 doi: 10.3390/biomedicines12071467
20
J Xue, W Zhu, J Song, Y Jiao, J Luo, C Yu, J Zhou, J Wu, M Chen, W-Q Ding, J Cao, S Zhang. Activation of PPARα by clofibrate sensitizes pancreatic cancer cells to radiation through the Wnt/β-catenin pathwayOncogene 2018; 37(7): 953 doi: 10.1038/onc.2017.401
21
Xi Ma, Lin Zhou, Shusen Zheng. Transcriptome analysis revealed key prognostic genes and microRNAs in hepatocellular carcinomaPeerJ 2020; 8: e8930 doi: 10.7717/peerj.8930
22
Jukun Wang, Ke Han, Chao Zhang, Xin Chen, Yu Li, Linzhong Zhu, Tao Luo. Identification and validation of ADME genes as prognosis and therapy markers for hepatocellular carcinoma patientsBioscience Reports 2021; 41(5) doi: 10.1042/BSR20210583
23
Ming-Liang Cheng, Yuan-Fu Lu, Hong Chen, Zhong-Yang Shen, Jie Liu. Liver expression of Nrf2-related genes in different liver diseasesHepatobiliary & Pancreatic Diseases International 2015; 14(5): 485 doi: 10.1016/S1499-3872(15)60425-8
24
Martin Krkoška, Jana Svobodová, Markéta Kabátková, Ondřej Zapletal, Alena Hyršlová Vaculová, Jana Nekvindová, Jan Vondráček. Deregulation of signaling pathways controlling cell survival and proliferation in cancer cells alters induction of cytochrome P450 family 1 enzymesToxicology 2021; 461: 152897 doi: 10.1016/j.tox.2021.152897
25
Jie Pan, Yuan Lu, Shuai Zhang, Yueting Li, Jia Sun, Hua Chunhua Liu, Zipeng Gong, Jing Huang, Chuang Cao, Yonglin Wang, Yongjun Li, Ting Liu. Differential changes in the pharmacokinetics of doxorubicin in diethylnitrosamine-induced hepatocarcinoma model ratsXenobiotica 2020; 50(10): 1251 doi: 10.1080/00498254.2020.1765049
26
Sudhir Kumar, Jiang Wang, Richa Rani, Chandrashekhar R. Gandhi, Gianfranco Alpini. Hepatic Deficiency of Augmenter of Liver Regeneration Exacerbates Alcohol-Induced Liver Injury and Promotes Fibrosis in MicePLOS ONE 2016; 11(1): e0147864 doi: 10.1371/journal.pone.0147864
27
Xiaoyan Li, Yiyan Lu, Xiaojun Ou, Sijing Zeng, Ying Wang, Xiaoxiao Qi, Lijun Zhu, Zhongqiu Liu. Changes and sex- and age-related differences in the expression of drug metabolizing enzymes in a KRAS-mutant mouse model of lung cancerPeerJ 2020; 8: e10182 doi: 10.7717/peerj.10182
28
Gargi Dixit, Arati Prabhu. The pleiotropic peroxisome proliferator activated receptors: Regulation and therapeuticsExperimental and Molecular Pathology 2022; 124: 104723 doi: 10.1016/j.yexmp.2021.104723
29
Tongmeng Yan, Linlin Lu, Cong Xie, Jiamei Chen, Xiaojuan Peng, Lijun Zhu, Ying Wang, Qiang Li, Jian Shi, Fuyuan Zhou, Ming Hu, Zhongqiu Liu. Severely Impaired and Dysregulated Cytochrome P450 Expression and Activities in Hepatocellular Carcinoma: Implications for Personalized Treatment in PatientsMolecular Cancer Therapeutics 2015; 14(12): 2874 doi: 10.1158/1535-7163.MCT-15-0274
30
Jianqing Yu, Nuozhou Wang, Zhongqin Gong, Liping Liu, Shengli Yang, George Gong Chen, Paul Bo San Lai. Cytochrome P450 1A2 overcomes nuclear factor kappa B-mediated sorafenib resistance in hepatocellular carcinomaOncogene 2021; 40(3): 492 doi: 10.1038/s41388-020-01545-z
31
Florian Klomp, Christoph Wenzel, Marek Drozdzik, Stefan Oswald. Drug–Drug Interactions Involving Intestinal and Hepatic CYP1A EnzymesPharmaceutics 2020; 12(12): 1201 doi: 10.3390/pharmaceutics12121201
32
João Victor Dutra Gomes, Corinna Herz, Simone Helmig, Nadja Förster, Inga Mewis, Evelyn Lamy. Drug-Drug Interaction Potential, Cytotoxicity, and Reactive Oxygen Species Production of Salix Cortex Extracts Using Human Hepatocyte-Like HepaRG CellsFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.779801
33
Jianwai Ren, George G. Chen, Yi Liu, Xianwei Su, Baoguang Hu, Billy C. S. Leung, Y. Wang, Rocky L. K. Ho, Shengli Yang, Gang Lu, C. G. Lee, Paul B. S. Lai, Zhiyuan Gong. Cytochrome P450 1A2 Metabolizes 17β-Estradiol to Suppress Hepatocellular CarcinomaPLOS ONE 2016; 11(4): e0153863 doi: 10.1371/journal.pone.0153863
34
Martin Krkoška, Jana Nekvindová, Kateřina Nevědělová, Veronika Zubáňová, Lenka Radová, Jan Vondráček, Jarmila Herůdková, Ondřej Slabý, Igor Kiss, Lucia Bohovicová, Pavel Fabian, Zuzana Tylichová, Zdeněk Kala, Petr Kysela, Lenka Ostřížková, Vladimír Palička, Alena Hyršlová Vaculová. Role of miR-653 and miR-29c in downregulation of CYP1A2 expression in hepatocellular carcinomaPharmacological Reports 2022; 74(1): 148 doi: 10.1007/s43440-021-00338-9
35
Yuseok Moon, Tamás Korcsmáros, Arulkumar Nagappan, Navin Ray. MicroRNA target-based network predicts androgen receptor-linked mycotoxin stressEcotoxicology and Environmental Safety 2022; 230: 113130 doi: 10.1016/j.ecoenv.2021.113130
36
Jiaqi Wang, Lushan Yu, Huidi Jiang, Xiaoli Zheng, Su Zeng. Epigenetic Regulation of Differentially Expressed Drug-Metabolizing Enzymes in CancerDrug Metabolism and Disposition 2020; 48(9): 759 doi: 10.1124/dmd.120.000008
37
Manuela G. Neuman, Stephen Malnick, Yaakov Maor, Radu M. Nanau, Ehud Melzer, Peter Ferenci, Helmut K. Seitz, Sebastian Mueller, Haim Mell, Didier Samuel, Lawrence B. Cohen, Kusum K. Kharbanda, Natalia A. Osna, Murali Ganesan, Kyle J. Thompson, Iain H. McKillop, Abraham Bautista, Ramon Bataller, Samuel W. French. Alcoholic liver disease: Clinical and translational researchExperimental and Molecular Pathology 2015; 99(3): 596 doi: 10.1016/j.yexmp.2015.09.001
38
X. Tang, L. Ge, Z. Chen, S. Kong, W. Liu, Y. Xu, S. Zeng, S. Chen. Methylation of the Constitutive Androstane Receptor Is Involved in the Suppression of CYP2C19 in Hepatitis B Virus-Associated Hepatocellular CarcinomaDrug Metabolism and Disposition 2016; 44(10): 1643 doi: 10.1124/dmd.116.070243
39
Haixing Li, Jed N. Lampe. Neonatal cytochrome P450 CYP3A7: A comprehensive review of its role in development, disease, and xenobiotic metabolismArchives of Biochemistry and Biophysics 2019; 673: 108078 doi: 10.1016/j.abb.2019.108078
40
Yu-Jie Jiang, Ye-Ming Cao, Yong-Bing Cao, Tian-Hua Yan, Cheng-Lin Jia, Ping He. A Review: Cytochrome P450 in Alcoholic and Non-Alcoholic Fatty Liver DiseaseDiabetes, Metabolic Syndrome and Obesity 2024; : 1511 doi: 10.2147/DMSO.S449494
41
Jana Nekvindova, Alena Mrkvicova, Veronika Zubanova, Alena Hyrslova Vaculova, Pavel Anzenbacher, Pavel Soucek, Lenka Radova, Ondrej Slaby, Igor Kiss, Jan Vondracek, Alena Spicakova, Lucia Bohovicova, Pavel Fabian, Zdenek Kala, Vladimir Palicka. Hepatocellular carcinoma: Gene expression profiling and regulation of xenobiotic-metabolizing cytochromes P450Biochemical Pharmacology 2020; 177: 113912 doi: 10.1016/j.bcp.2020.113912
42
Yan Tan, Mina Wang, Ke Yang, Tiange Chi, Zehuan Liao, Peng Wei. PPAR-α Modulators as Current and Potential Cancer TreatmentsFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.599995
43
Ettore Mosca, Roberta Alfieri, Luciano Milanesi, Ranjit Ray. Diffusion of Information throughout the Host Interactome Reveals Gene Expression Variations in Network Proximity to Target Proteins of Hepatitis C VirusPLoS ONE 2014; 9(12): e113660 doi: 10.1371/journal.pone.0113660
44
Jeong Eun Yoo, Ji Hae Nahm, Young-Joo Kim, Youngsic Jeon, Young Nyun Park. The dual role of transforming growth factor-beta signatures in human B viral multistep hepatocarcinogenesis: early and late responsive genesJournal of Liver Cancer 2022; 22(2): 115 doi: 10.17998/jlc.2022.04.20
45
Xianqiang Zhou, Fang Tan, Suxian Zhang, An'an Wang, Tiansong Zhang. A Strategy based on Bioinformatics and Machine Learning Algorithms Reveals Potential Mechanisms of Shelian Capsule against Hepatocellular CarcinomaCurrent Pharmaceutical Design 2024; 30(5): 377 doi: 10.2174/0113816128284465240108071554
46
Maya Okamura, Ryota Shizu, Takuomi Hosaka, Takamitsu Sasaki, Kouichi Yoshinari. Possible involvement of the competition for the transcriptional coactivator glucocorticoid receptor-interacting protein 1 in the inflammatory signal-dependent suppression of PXR-mediated CYP3A induction in vitroDrug Metabolism and Pharmacokinetics 2019; 34(4): 272 doi: 10.1016/j.dmpk.2019.04.005
47
Cheng-Lin Fu, Bing Pan, Ju-Hua Pan, Mei-Fu Gan. Metallothionein 1M suppresses tumorigenesis in hepatocellular carcinomaOncotarget 2017; 8(20): 33037 doi: 10.18632/oncotarget.16521
48
D. Desaulniers, N. Khan, C. Cummings-Lorbetskie, K. Leingartner, G-H. Xiao, A. Williams, C.L. Yauk. Effects of cross-fostering and developmental exposure to mixtures of environmental contaminants on hepatic gene expression in prepubertal 21 days old and adult male Sprague-Dawley ratsJournal of Toxicology and Environmental Health, Part A 2019; 82(1): 1 doi: 10.1080/15287394.2018.1542360
49
Hyuk Soo Eun, Sang Yeon Cho, Byung Seok Lee, Sup Kim, In‐Sang Song, Kwangsik Chun, Cheong‐Hae Oh, Min‐Kyung Yeo, Seok Hyun Kim, Kyung‐Hee Kim. Cytochrome P450 4A11 expression in tumor cells: A favorable prognostic factor for hepatocellular carcinoma patientsJournal of Gastroenterology and Hepatology 2019; 34(1): 224 doi: 10.1111/jgh.14406
50
Ruohao Zhang, Miao Huang, Hong Wang, Shengming Wu, Jiali Yao, Yingying Ge, Yufei Lu, Qiping Hu. Identification of Potential Biomarkers From Hepatocellular Carcinoma With MT1 DeletionPathology and Oncology Research 2021; 27 doi: 10.3389/pore.2021.597527
51
Christoph G Dietrich, Oliver Götze, Andreas Geier. Molecular changes in hepatic metabolism and transport in cirrhosis and their functional importanceWorld Journal of Gastroenterology 2016; 22(1): 72-88 doi: 10.3748/wjg.v22.i1.72